Akeso Biomedical is an early stage company focused on developing new solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds. The Company is developing products to treat these conditions using a new class of compounds, known as Fe3C, that have broad-spectrum activity against a wide range of bacteria, and a silk biomaterial technology exclusively licensed from Tufts University.

Biotechnology

Akeso Biomedical

Akeso Biomedical's headquarters in Waltham, MA, United States

Simon Williams

Scott Roth

Akeso Biomedical

Org chart

Board & advisors

Teams

Leadership Team

Offices

Similar companies